Search research articles
Contact Us
Filters
Showing results (21-30 of 470) with videos related to
Page
of 47
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2009
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Cholinesterase inhibitors in Alzheimer's disease--evidence-based or evidence-biased?
Krista L Lanctôt, Nathan Herrmann
Lancet (London, England)
|
February 5, 2016
Long-term effects of lithium on renal function
Soham Rej, Kenneth Shulman, Nathan Herrmann
Journal of Geriatric Psychiatry and Neurology
|
April 3, 2012
The effects of lithium on renal function in older adults--a systematic review
Soham Rej, Nathan Herrmann, Kenneth Shulman
Expert Opinion on Pharmacotherapy
|
March 10, 2011
Memantine in dementia: a review of the current evidence
Nathan Herrmann, Abby Li, Krista Lanctôt
CNS Drugs
|
June 1, 2011
Transdermal rivastigmine: management of cutaneous adverse events and review of the literature
Jill Greenspoon, Nathan Herrmann, David N Adam
The Journal of Clinical Psychiatry
|
August 26, 2016
Dr Mazereeuw and Colleagues Reply
Graham Mazereeuw, Krista L Lanctôt, Nathan Herrmann
The American Journal of Psychiatry
|
June 1, 2004
Atypical antipsychotics and risk of cerebrovascular accidents
Nathan Herrmann, Muhammad Mamdani, Krista L Lanctôt
Expert Opinion on Drug Safety
|
September 1, 2004
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease
Sarah Thompson, Krista L Lanctôt, Nathan Herrmann
Journal of Affective Disorders
|
February 13, 2017
Ceramides and depression: A systematic review
Adam Dinoff, Nathan Herrmann, Krista L Lanctôt
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2009
Clinical practice guidelines for severe Alzheimer's disease
Nathan Herrmann, Serge Gauthier, Paul G Lysy
Page
of 47
Search research articles
Search
Showing results (21-30 of 470) with videos related to
Sort By:
Page
of 47
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2009
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Cholinesterase inhibitors in Alzheimer's disease--evidence-based or evidence-biased?
Krista L Lanctôt, Nathan Herrmann
Lancet (London, England)
|
February 5, 2016
Long-term effects of lithium on renal function
Soham Rej, Kenneth Shulman, Nathan Herrmann
Journal of Geriatric Psychiatry and Neurology
|
April 3, 2012
The effects of lithium on renal function in older adults--a systematic review
Soham Rej, Nathan Herrmann, Kenneth Shulman
Expert Opinion on Pharmacotherapy
|
March 10, 2011
Memantine in dementia: a review of the current evidence
Nathan Herrmann, Abby Li, Krista Lanctôt
CNS Drugs
|
June 1, 2011
Transdermal rivastigmine: management of cutaneous adverse events and review of the literature
Jill Greenspoon, Nathan Herrmann, David N Adam
The Journal of Clinical Psychiatry
|
August 26, 2016
Dr Mazereeuw and Colleagues Reply
Graham Mazereeuw, Krista L Lanctôt, Nathan Herrmann
The American Journal of Psychiatry
|
June 1, 2004
Atypical antipsychotics and risk of cerebrovascular accidents
Nathan Herrmann, Muhammad Mamdani, Krista L Lanctôt
Expert Opinion on Drug Safety
|
September 1, 2004
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease
Sarah Thompson, Krista L Lanctôt, Nathan Herrmann
Journal of Affective Disorders
|
February 13, 2017
Ceramides and depression: A systematic review
Adam Dinoff, Nathan Herrmann, Krista L Lanctôt
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2009
Clinical practice guidelines for severe Alzheimer's disease
Nathan Herrmann, Serge Gauthier, Paul G Lysy
Page
of 47